Total trials
288
Active
39
Phase 3
6
Total enrollment
675,603
Pipeline matrix
Showing 14 of 14 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Metoprolol Succinate | — | — | — | — | — | 1 | |
| Bisoprolol | — | — | — | — | — | 1 | |
| Carvedilol | — | — | — | — | — | 1 | |
| Nebivolol | — | — | — | — | — | 1 | |
| Eplerenone | — | — | — | — | — | 1 | |
| Spironolactone | — | — | — | — | — | 1 | |
| Naproxen 500 Mg | — | — | — | — | — | 2 | |
| Sodium chloride | — | — | — | — | 2 | ||
| Growth hormone | — | — | — | — | — | 1 | |
| Semaglutide, 0.5 mg/mL | — | — | — | — | — | 1 | |
| Glucagon | — | — | — | — | — | 1 | |
| Glucagon+Exendin9-39 | — | — | — | — | — | 1 | |
| Corticosteroid | — | — | — | — | — | 1 | |
| Local anesthesia injections | — | — | — | — | — | 1 |
Next readouts
- 2024-11-04
- 2025-03
- 2025-04-01
- 2025-07-31
- 2027-06-01
- 2027-11-01
- 2028-12-31
Top conditions
- Asthma17
- Sarcopenia9
- Tendinopathy8
- Obesity8
- Stroke7
- Hernia, Ventral6
- Cancer6
- Postoperative Complications5
Frequently asked questions about Bispebjerg Hospital
- How many clinical trials does Bispebjerg Hospital have on ClinicalTrials.gov?
- Bispebjerg Hospital is listed as the lead sponsor on 288 clinical trials in ClinicalTrials.gov, 39 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Bispebjerg Hospital's trials are in Phase 3?
- 6 of Bispebjerg Hospital's trials are in Phase 3, spread across 14 active drug programs.
- What therapeutic areas does Bispebjerg Hospital focus on?
- Bispebjerg Hospital's most-studied conditions on ClinicalTrials.gov are Asthma, Sarcopenia, Tendinopathy, Obesity, Stroke.
- When are Bispebjerg Hospital's next clinical trial readouts?
- Bispebjerg Hospital has 7 upcoming primary-completion readouts tracked here; the soonest is “Resistance Training and Injection Treatment for Achilles Enthesopathy”, expected around 2024-11-04.